Frontlight ResearchEarly access
Lung cancer trials in United States
900 trials · From ClinicalTrials.gov, checked 16 November 2026. Ask the study team whether a trial fits you.
- Phase 1Taking peoplePhase 1 Study Of Izalontamab Brengitecan + Adagrasib In NSCLC - The IZA-A Trial
- Where
- Houston
- Age
- 18 years and over
- People
- 18
- Run by
- M.D. Anderson Cancer Center
See details and how to joinNCT07382726 - No phaseTaking peopleCancer-related Fatigue During Maintenance Immunotherapy for Non-small Cell Lung Cancer (NSCLC): a Qualitative Study
- Where
- Charlotte, Winston-Salem
- Age
- 18 years and over
- People
- 20
- Run by
- Wake Forest University Health Sciences
See details and how to joinNCT06567704 - Phase 1/2Taking peopleA Study of DM005 in Patients With Advanced Solid Tumors
- Where
- Dallas, Detroit, Fairfax
- Age
- 18 years and over
- People
- 208 worldwide
- Run by
- Doma Biopharmaceutical(Suzhou)Co., Ltd.
See details and how to joinNCT06515990 - No phaseEnrolling by invitationFacilitation of Information eXchange for Shared Decision Making for Lung Cancer Screening
- Where
- Worcester
- Age
- 50 years to 77 years
- People
- 120
- Run by
- University of Massachusetts, Worcester
See details and how to joinNCT07517692 - No phaseTaking peoplePET/CT Changes During Chemoimmunotherapy and Radiation Therapy in Patients With Stage IV Non-small Cell Lung Cancer
- Where
- Seattle
- Age
- 18 years and over
- People
- 80
- Run by
- University of Washington
See details and how to joinNCT04151940 - Phase 1Taking peopleStudy of Osimertinib With Carotuximab in Advanced, EGFR-mutated Non-Small Cell Lung Cancer
- Where
- Beverly Hills, Los Angeles, Torrance
- Age
- 18 years and over
- People
- 60
- Run by
- Karen Reckamp, MD, MS
See details and how to joinNCT05401110 - No phaseTaking peopleImmunobiology Blood and Tissue Collection of Upper Aerodigestive Malignancies
- Where
- Baltimore
- Age
- 18 years and over
- People
- 1,250
- Run by
- Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
See details and how to joinNCT05995821 - Phase 3Taking peopleA Study of Ifinatamab Deruxtecan Versus Treatment of Physician's Choice in Subjects With Relapsed Small Cell Lung Cancer
- Where
- Baltimore, Boston, Canton, Chicago, Cincinnati, Detroit, East Brunswick, Fullerton, Germantown, Houston, Lake Success, Lebanon, Lexington, Los Angeles, Miami, Milwaukee, Neptune City, New York, Omaha, Orlando, Portland, San Francisco, Springdale, St Louis, Tampa, The Bronx, Tyler
- Age
- 18 years and over
- People
- 540 worldwide
- Run by
- Daiichi Sankyo
See details and how to joinNCT06203210 · EU 2023-509628-16-00 - No phaseTaking peopleLUNG-07: Advancing Precision-Based Lung Cancer Screening: Implementation, AI-Guided Risk Stratification, and Biomarker Integration (CREST AI)
- Where
- Chicago
- Age
- 50 years to 80 years
- People
- 2,500
- Run by
- University of Illinois Chicago
See details and how to joinNCT07408531 - Phase 1Taking peopleIDOV-Immune for Advanced Solid Tumors
- Where
- Houston, San Antonio, St Louis
- Age
- 18 years and over
- People
- 78 worldwide
- Run by
- ViroMissile, Inc.
See details and how to joinNCT06910657 - No phaseTaking peoplePrecise Exercise Regimen for Cancer Care (PERCC): A Pilot Study
- Where
- Boston
- Age
- 18 years and over
- People
- 20
- Run by
- Dana-Farber Cancer Institute
See details and how to joinNCT07412041 - Phase 1Taking peopleStudy Evaluating the Safety and Efficacy of HWK-007, a PTK7-directed Antibody Drug Conjugate in Participants With Advanced Solid Tumors
- Where
- Austin, Buffalo, Cleveland, Fairfax, Grand Rapids, Hackensack, Houston, Little Rock, Los Angeles, Peoria, San Antonio, Seattle
- Age
- 18 years and over
- People
- 226
- Run by
- Whitehawk Therapeutics, Inc.
See details and how to joinNCT07444814 - No phaseTaking peopleSupport for Cancer Patients Awaiting News
- Where
- Hackensack
- Age
- 18 years and over
- People
- 60
- Run by
- Hackensack Meridian Health
See details and how to joinNCT06199570 - Phase 1Taking peopleDSP-0390 in Combination With Atezolizumab for Small Cell Lung Cancer
- Where
- St Louis
- Age
- 18 years and over
- People
- 20
- Run by
- Washington University School of Medicine
See details and how to joinNCT07545954 - Phase 1Taking peopleStudy of XmAb®819 in Subjects With Advanced Clear Cell Renal Cell Carcinoma
- Where
- Atlanta, Charlotte, Chicago, Cincinnati, Columbus, Duarte, Durham, Jacksonville, Louisville, Nashville, New Brunswick, New Haven, New York, Oklahoma City, Phoenix, Rochester, Sacramento, Seattle
- Age
- 18 years and over
- People
- 307 worldwide
- Run by
- Xencor, Inc.
See details and how to joinNCT05433142 · EU 2024-513619-28-00 - Phase 1/2Taking peoplePhase I/II Randomized Study of NBTXR3 Activated by Abscopal or RadScopal Radiation in Combination With Immunotherapy (Anti-PD-1/L-1) for Patients With Advanced Solid Malignancies
- Where
- Houston
- Age
- 18 years and over
- People
- 40
- Run by
- M.D. Anderson Cancer Center
See details and how to joinNCT05039632 - No phaseTaking peopleCardiopulmonary Monitoring in Lung Cancer Patients Receiving Combined Thoracic Radiotherapy and Immunotherapy
- Where
- Columbia, New Brunswick, Rochester
- Age
- 18 years and over
- People
- 125
- Run by
- Bo Lu
See details and how to joinNCT06410300 - Phase 1Taking peopleAMG 410 Alone and in Combination With Other Agents in Participants With KRAS Altered Advanced or Metastatic Solid Tumors
- Where
- Atlanta, Boston, Duarte, Durham, Fairfax, Los Angeles, Nashville, Philadelphia, San Antonio, St Louis
- Age
- 18 years and over
- People
- 434 worldwide
- Run by
- Amgen
See details and how to joinNCT07094113 - Phase 2Taking peopleREStoring lymphoCytes Using NKTR-255* After chemoradiothErapy in Solid Tumors (RESCUE)
- Where
- Houston
- Age
- 18 years and over
- People
- 39
- Run by
- M.D. Anderson Cancer Center
See details and how to joinNCT05632809 - Phase 1Taking peoplePhase I Study of [177Lu]Lu-NNS309 in Patients With Pancreatic, Lung, Breast and Colorectal Cancers
- Where
- Birmingham, Boston, Grand Rapids, Houston, Jacksonville, Los Angeles, Palo Alto, Rochester, Seattle
- Age
- 18 years to 100 years
- People
- 162 worldwide
- Run by
- Novartis Pharmaceuticals
See details and how to joinNCT06562192 - Phase 1Taking peopleA Study of BMS-986488 as Monotherapy and Combination Therapy in Participants With Advanced Malignant Tumors
- Where
- Allentown, Dallas, Germantown, Hackensack
- Age
- 18 years and over
- People
- 437 worldwide
- Run by
- Bristol-Myers Squibb
See details and how to joinNCT06764771 - No phaseTaking peopleSignature Development and Validation Protocol for an Epigenetic Assay in Diagnosing Lung Cancer
- Where
- Glen Burnie
- Age
- 18 years and over
- People
- 750
- Run by
- University of Maryland, Baltimore
See details and how to joinNCT07008664 - No phaseNot yet taking people in United StatesSymptom Management to Improve Completion of Patient-reported Outcome Measures
- Where
- Detroit
- Age
- 18 years and over
- People
- 78
- Run by
- Henry Ford Health System
See details and how to joinNCT07723495 - No phaseNot yet taking people in United StatesA Stepped Intervention for Coping With Dyspnea in Patients With Lung Cancer-Phase A (Open Pilot)
- Where
- Boston
- Age
- 18 years and over
- People
- 10
- Run by
- Massachusetts General Hospital
See details and how to joinNCT07728773 - No phaseNot yet taking people in United StatesAnalysis of Breath Volatile Organic Compounds Using Mass Spectrometry
- Where
- Oklahoma City
- Age
- 18 years and over
- People
- 2,000
- Run by
- University of Oklahoma
See details and how to joinNCT07732686